Our Experts

Driven by a passion for patients. Underpinned by serious expertise.
We share your passion for bringing effective new therapies to the patients who need them. We succeed through operational expertise, translational science expertise, and medical expertise, all focused on oncology and rare disease development. We stand shoulder-to-shoulder with you through every stage of your trial, delivering a hands-on approach to the clinical development of personalized medicine—one team, dedicated to one result.
We're sorry, there are no results for "".
  • Ali Sadighian

    Senior Vice President Business Operations

    Accomplished and versatile leader with clinical development and R&D experience gained from academia, biopharma, and several top CROs. Senior executive with unique skills gleaned in laboratory research at the UCSD School of Medicine, in quality control in the biotech industry, and in clinical operations. Dedicated to helping innovative companies bring new therapies to patients and families in greatest need.

    Name here
  • Andrea Cotton-Berry, MSc

    Global Head of Strategic Development

    Notable authority in global operations dedicated to fostering team spirit of excellence and collaboration with internal and external partners. Veteran of the quest to improve oncology therapies and extend lives, including 15+ years in oncology drug development, building on 10 years in Obstetrics and Women’s Health.

    Name here
  • Chad Clark

    President, Precision for Medicine

    Recognized industry leader focused on combining cutting-edge technology, strategic program design, and operational excellence to help life sciences companies effectively address the increasing evidence demands and need to accelerate research initiatives. Previous experience spans the execution of phase 1–4 clinical trials, specialty lab services, biospecimen logistics and banking, risk management, and patient support initiatives.

    Name here
  • Cheryl Ruiz

    Executive Director of Clinical Operations, Europe

    Global clinical research and pharmaceutical services veteran, with expertise managing phase 1–4 clinical trials and global development programs. Dedicated mentor to project management and clinical staff, providing strategic and practical support to assigned teams. Authority in European processes and capabilities across many areas of oncology and hematology.

    Name here
  • Christopher A. Ellis

    Senior Director Business Development

    Established international clinical research executive. Leading expert in support of phase 1–3 programs with a strong background in oncology clinical research. Primary business development contact for biotech and pharmaceutical clients on the east coast.

    Name here
  • Clare Sarvary Fourrier

    Senior Vice President Clinical Operations - Europe

    Veteran of global oncology clinical operations, with in-depth experience in phase 1–3 oncology and hematology research as well as early-phase studies. Builder of world-class oncology research teams and leader of strategic growth of resources and operations across Europe. Keenly focused on study delivery, mitigation of study risk, and client service.

    Name here
  • David Parker, PhD

    Senior Vice President Diagnostics Solutions

    Strategic visionary and healthcare industry veteran operates at the intersection of reimbursement, health economics, clinical science, and marketing strategy. Expertise encompasses all aspects of market access, reimbursement, and evidence development strategy, with a particular focus on personalized medicine, advanced molecular and companion diagnostics, and targeted therapies. Has launched successful products, guided major investment and acquisition decisions, and driven favorable coverage and payment determinations by public and private payers alike. Speaker and author.

    Name here
  • Deborah Phippard, PhD

    Senior Vice President Research Services

    Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.

    Name here
  • Elizabeth Ludington, PhD

    Senior Vice President Biometrics

    Seasoned industry veteran with deep experience in the pharmaceutical and biotech, CROs and sponsor companies. Provider of statistical, technical, and strategic expertise for preclinical studies, INDs, phase 1–4 clinical studies, electronic Common Technical Documents, and postmarketing studies.  Statistical consultant for programs at all phases of development, skilled at representing clients at meetings with regulatory authorities and delivering study design, protocol review, and analysis plans and statistical reports.

    Name here
  • Ellen Morgan, MS

    President Rare Disease

    Industry innovator, passionate about helping underserved patient populations and keenly focused on orphan drug development. Serial entrepreneur, founder of Agility Clinical and Synteract. Seasoned expert in biostatistics, data management, and clinical operations. Accomplished executive with numerous awards including Most Admired CEO,  100 Most Inspiring People in the Pharmaceutical Industry, Athena Pinnacle Award for Women in Science and Technology, and Ernst & Young Entrepreneur of the Year Finalist.

    Name here
  • Frances Murphy

    Senior Director of Strategic Development EU & APAC

    Leading authority in clinical CROs, focused on client services and regional growth implementation. Dedicated proponent of harnessing truly personalized medicine to develop more effective treatments for patients with advanced cancers. Brings that passion to client support.

    Name here
  • Gerald Messerschmidt, MD, FACP

    Chief Medical Officer Oncology Solutions

    Oncologist, hematologist and veteran expert in clinical research, clinical practice and development of pharmaceuticals, biologic products and immune modulation therapies. Dr. Messerschmidt was a primary consultant to the Moonshot 2020 program and is an authority in optimizing clinical trial designs to accelerate product approval. He has significant experience and credibility with the FDA and with regulatory authorities in Europe, Japan and other countries.

    Name here
  • Jared Kohler, PhD

    Senior Vice President Translational Informatics and Biometrics

    Recognized authority across the pharmaceutical and biotech space—translational research, data management, and statistical support—with a focus in precision medicine-guided efforts in drug and diagnostic development. Subject matter expert in genomics. Pioneer of innovative biomarker data management approaches. Leader of biometrics operations on over 70 clinical studies.

    Name here
  • Jeffrey D. Seroskie, MS

    Senior Vice President Oncology

    Seasoned executive charged with global governance of international trials and optimizing execution and delivery of all clinical. Key member on the development teams for multiple registered products: Taxotere® (docetaxel), Tykerb® (lapatinib), Revlimid® (lenalidomide), Thalomid® (thalidomide), and Kyprolis® (carfilzomib).

    Name here
  • Joseph A. Parks, MS, RQAP-GCP

    Senior Vice President Quality and Compliance

    Seasoned leader of pharmaceutical companies and global CROs with specialized expertise in the operational application of ICH/GCP Guidelines and FDA regulations. Veteran of pre-IND meetings, IND submissions, New Drug Applications (NDA eCTD format) and Marketing Authorization Applications (MAA eCTD format). Extensive experience running SOP development, ICH/GCP guidelines, compliance inspection readiness, vendor assessment/selection, partnering and management. Ensures regulatory compliance in all phases of client drug development.

    Name here
  • Julia Amo, MBA, PMP

    Chief Operating Officer Oncology

    Expert strategist for the pharmaceutical, CRO, and healthcare industries, with extensive multidisciplinary drug development experience at the project, compound, and portfolio levels and a sophisticated approach to operations and infrastructure.

    Name here
  • Karen Richards

    Senior Vice President In Vitro Diagnostics and Quality

    Leader and innovator in the GMP/ISO/FDA/EU-regulated in vitro diagnostic (IVD) industry. Spearheads regulatory approvals worldwide for both novel and traditional IVD assays and products, as well as laboratory developed tests in the United States. Builds ground-up quality systems, meeting the requirements of US FDA, ISO 13485, CLIA, and CAP.

    Name here
  • Kristi Clark, MBA

    Senior Vice President Project Management and Clinical Operations Rare Disease

    Global business strategist with 20+ years of experience in the biopharma and CRO industries. Project and clinical management expert,  knowledgeable in the full scope of studies and therapeutic areas including pediatric oncology, pediatric chronic pain, cancer pain, oncology, cardiovascular, CNS, biomarkers, infectious disease, gastroenterology, ophthalmology, cystic fibrosis, pediatric autoinflammatory disorders, stem cell research, genetic sampling, and medical devices.

    Name here
  • Marilyn Carlson, DMD, MD, RAC

    Senior Vice President Medical, Regulatory, and Scientific Affairs, Rare Disease

    Industry veteran known for the development, approval, and postmarketing support of pharmaceutical products across a wide variety of therapeutic indications, with deep experience in medical, pharmaceutical, dental, regulatory, safety, and clinical development. Recognized for her passion for working with start-up companies and entrepreneurs in the life sciences, where no task is too big or too small.

    Name here
  • Maureen Higgins, PhD, MBA

    Executive Director Operations, Europe

    Longstanding authority in clinical management of global phase I-IV trials, spanning roles across clinical operations, project management, operations management, and business development. Specialist in oncology early-phase development with insight into all aspects of clinical research from startup to marketing submissions, including study oversight, risk mitigation, and face-to-face meetings with competent authorities in Europe and the FDA. Leader renowned for being calm in challenging situations, able to react effectively to rapidly changing circumstances without losing focus on the key objectives to be achieved.

    Name here
  • Patricia Devitt Risse, PharmD

    President Oncology

    Industry innovator, integrating teams to combine the strength of biomarker insights with clinical outcome data to optimize the development pathway of novel oncology therapies. Founder of ACT Oncology. Noted expert in phase 1–4 trials for most indications, including solid tumor and hematologic malignancies. Leader of strategic protocol design and study optimization on behalf of the company’s sponsors.

    Name here
  • Patricia Terek, MSc

    Senior Director Business Development

    Healthcare industry veteran of 30+ years, bridging business development efforts and program implementation for optimal client satisfaction. Expert in managing domestic and global sales teams with results-driven ability to generate revenue, achieve sales targets, lead process improvements, and implement and manage CRM systems.

    Name here
  • Rajiv Mahadevan, MBA

    Managing Director

    Key strategist with broad management expertise spanning operations, sales, business development, and program management across the life sciences industry. Cofounded Applied Immunology, which was acquired by Precision in 2016. Served as global health strategist for the Bill & Melinda Gates Foundation. Led business development efforts at 23andMe. Was centrally engaged in product development and commercialization for a multi-billion-dollar novel therapeutic at Amgen.

    Name here
  • Robert Ott, MBA

    Vice President Business Operations, Oncology

    Experienced industry veteran with deep knowledge of the contract research/pharmaceutical services industry. Executive supporting clients through operational oversight, resource allocation, and internal business strategy, structuring Precision operations to match client needs.

    Name here
  • Roberto Lara

    Senior Director Business Operations, Head of Canadian Operations

    International CRO authority with 18+ years in the oncology drug development industry, spanning commercial operations, oncology and clinical operations, partnership development, and investigator networking.

    Name here
  • Scott Marshall, PhD

    Managing Director Translational Informatics and Diagnostic Sciences

    Veteran expert across the pharmaceutical and biotech space—diagnostics regulatory submissions, translational informatics, biomarker R&D—with a focus in precision medicine–guided efforts as well as strategy development and medical device/diagnostic development. Leader of translational informatics R&D efforts. Authority on novel methodologies for patient stratification and biomarker guided clinical trial design.

    Name here
  • Tandy R. Tipps, PhD

    Vice President Precision Oncology Site Network, Oncology

    Seasoned executive and leader of Precision Oncology Site Network, dedicated to consistently optimizing start-up at both academic and community-based sites across the United States and Europe. Previously oversaw the world’s largest phase 1 program for cancer research and treatment at the renowned University of Texas MD Anderson Cancer Center.

    Name here
  • Vashi Patel, PhD

    Director of Regulatory Oncology

    Prominent authority on regulations pertaining to the pharmaceutical industry, with a focus on emerging and small biotech companies. Expertise spanning early-development to postmarketing, navigating regulatory strategy and review, performing standard GAP assessments, developing SOPs, and leading teams through pre-IND and IND meeting planning, development, and submission activities.

    Name here

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics, adaptive clinical trial execution to regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

What kind of expertise do you need?

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.